635 results on '"Nam, Eun Ji"'
Search Results
2. Initial experience with the da Vinci SP robot-assisted surgical staging of endometrial cancer: a retrospective comparison with conventional laparotomy
3. Comparing surgical outcomes of da Vinci SP and da Vinci Xi for endometrial cancer surgical staging in a propensity score-matched study
4. Application of Small Cell Lung Cancer Molecular Subtyping Markers to Small Cell Neuroendocrine Carcinoma of the Cervix: NEUROD1 as a Poor Prognostic Factor
5. Histopathologic image–based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer
6. Comparison of single-port laparoscopy and laparotomy in early ovarian cancer surgical staging
7. Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial protocol
8. Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?
9. Characteristics of surgically transposed ovaries on 18F-FDG PET/CT among patients with cancer
10. Immunohistochemical and genetic characteristics of HPV-associated endocervical carcinoma with an invasive stratified mucin-producing carcinoma (ISMC) component
11. Comparison of surgical outcomes in single-port laparoscopy with sentinel lymph node biopsy in enhanced recovery after surgery (ERAS) protocol versus conventional laparoscopy surgery for endometrial cancer
12. The efficacy of subsequent chemotherapy in ovarian cancer patients who progressed in prior PARPi
13. Impact of clinical trial participation on the survival of patients with newly diagnosed advanced-stage ovarian cancer
14. PD-L1 as the key to survival for the advanced ovarian cancer previously treated with IDS-HIPEC
15. Ten-year survival impact of FDA warning on power morcellation in occult uterine leiomyosarcoma diagnosed after minimally invasive surgery
16. Changes in the tumor immune microenvironment during disease progression in clear cell ovarian cancer
17. Efficacy and safety of immune checkpoint inhibitor in clear cell ovarian cancer (CCC): the real world data
18. Evaluating the usefulness of HIPEC with secondary cytoreductive surgery: did we get the wrong end of the stick?
19. Retrospective study on postoperative pain control using bupivacaine-only injection and bupivacaine with gel injection after single port laparoscopic hysterectomy
20. Validation of the revised FIGO staging of endometrial cancer: identifying high-risk patients and upstaging them to stage II/article-title>
21. Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines
22. Secondary cytoreductive surgery with and without hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer
23. Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
24. Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
25. Survival outcomes of single-port access laparoscopic radical hysterectomy for early-stage cervical cancer
26. Comparison of Single-Port Laparoscopy with Other Surgical Approaches in Endometrial Cancer Surgical Staging: Propensity-Score-Matched Analysis
27. EP134/#1505 Dostarlimab monotherapy in mismatch repair deficient/microsatellite instability-high advanced or recurrent endometrial cancer in the Korean expanded access program
28. Mismatch repair, p53, and L1 cell adhesion molecule status influence the response to chemotherapy in advanced and recurrent endometrial cancer
29. #800 Could the preoperative status of P53 mutation and mismatch repair deficiency be useful as predictive biomarker for the extent of surgery in early-stage endometrial cancer patients?
30. Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy
31. Expression of programmed cell death ligand 1 and immune checkpoint markers in residual tumors after neoadjuvant chemotherapy for advanced high-grade serous ovarian cancer
32. Difference in Risk of Breast and Ovarian Cancer According to Putative Functional Domain Regions in Korean BRCA1/2 Mutation Carriers
33. Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure
34. Clinical Relevance of Red Blood Cell Distribution Width (RDW) in Endometrial Cancer: A Retrospective Single-Center Experience from Korea
35. Histopathologic Image-based Deep Learning Classifier for Predicting Platinum-based Treatment Responses in High-grade Serous Ovarian Cancer
36. Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer
37. Perioperative Outcomes of 3-Arm Versus 4-Arm Robotic Radical Hysterectomy in Patients with Cervical Cancer
38. Transcatheter Arterial Embolization for Severe Secondary Hemorrhage after Hysterectomy
39. Impact of the time interval from completion of neoadjuvant chemotherapy to initiation of postoperative adjuvant chemotherapy on the survival of patients with advanced ovarian cancer
40. Vaginal Cuff Dehiscence and a Guideline to Determine Treatment Strategy
41. Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer
42. Clinical Relevance of Vaginal Cuff Dehiscence after Minimally Invasive versus Open Hysterectomy
43. Abstract 200: Patient-derived cervical cancer organoids as a pre-clinical model predicting drug and radiation response
44. Abstract 1772: Development of a novel L1CAM-targeted CAR-T, CX804, and its therapeutic efficacy in ovarian and gastric cancer
45. Data from Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
46. Supplementary Data from EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma
47. Data from Functional Roles of Src and Fgr in Ovarian Carcinoma
48. Supplementary Data from Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
49. Supplementary Figures S1-S5 from Functional Roles of Src and Fgr in Ovarian Carcinoma
50. LncRNA SNHG4 Modulates EMT Signal and Antitumor Effects in Endometrial Cancer through Transcription Factor SP-1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.